和元生物
(688238)
| 流通市值：33.33亿 | | | 总市值：46.23亿 |
| 流通股本：4.67亿 | | | 总股本：6.47亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 566,941,878.98 | 657,048,399.97 | 779,440,193.58 | 887,909,514.57 |
| 应收票据及应收账款 | 57,505,609.35 | 69,200,040.79 | 73,682,261.7 | 88,018,306.41 |
| 应收账款 | 57,505,609.35 | 69,200,040.79 | 73,682,261.7 | 88,018,306.41 |
| 预付款项 | 7,480,025.31 | 6,470,141.32 | 10,909,758.62 | 8,601,114.57 |
| 其他应收款合计 | 2,172,575.02 | 1,890,228.57 | 11,266,577.98 | 2,173,713.14 |
| 存货 | 82,064,223.89 | 80,848,508.12 | 78,759,617.08 | 72,464,681.78 |
| 合同资产 | 32,261,170.28 | 19,765,208.55 | 21,268,143.31 | 14,135,257.84 |
| 其他流动资产 | 101,584,110.4 | 92,227,313.14 | 67,248,004.03 | 59,480,030.72 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 860,070,593.23 | 927,449,840.46 | 1,042,574,556.3 | 1,152,786,235.47 |
| 非流动资产: | | | | |
| 长期股权投资 | 66,376,783.46 | 66,922,038.29 | 67,477,500.39 | 41,096,338.65 |
| 其他权益工具投资 | 52,504,412.12 | 40,571,478.85 | 31,115,000 | 25,115,000 |
| 固定资产 | 1,165,490,422.98 | 1,045,862,859.74 | 702,775,067.93 | 197,300,660.88 |
| 在建工程 | 243,577,311.12 | 346,324,375.19 | 419,249,095.47 | 762,530,686.38 |
| 使用权资产 | 31,023,083.52 | 32,829,714.06 | 34,636,344.6 | 36,442,975.14 |
| 无形资产 | 55,010,967.69 | 55,491,731.97 | 52,465,513.86 | 50,940,500.4 |
| 长期待摊费用 | 38,743,541.25 | 40,223,556.19 | 74,118,368.95 | 53,347,199.24 |
| 递延所得税资产 | 56,167,074.55 | 47,816,630.75 | 36,945,832.26 | 30,923,500.26 |
| 其他非流动资产 | - | - | 160,139,314.44 | 160,139,314.44 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,708,893,596.69 | 1,676,042,385.04 | 1,578,922,037.9 | 1,357,836,175.39 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,568,964,189.92 | 2,603,492,225.5 | 2,621,496,594.2 | 2,510,622,410.86 |
| 流动负债: | | | | |
| 短期借款 | 60,016,666.66 | - | - | - |
| 应付票据及应付账款 | 176,469,880.93 | 228,501,697.51 | 195,555,264.31 | 76,278,324.36 |
| 应付账款 | 176,469,880.93 | 228,501,697.51 | 195,555,264.31 | 76,278,324.36 |
| 合同负债 | 23,346,514.04 | 35,037,513.31 | 26,627,299.47 | 20,994,470.83 |
| 应付职工薪酬 | 14,060,807.6 | 17,643,402.34 | 15,278,197.87 | 14,226,418.17 |
| 应交税费 | 5,538,528.45 | 6,417,428.56 | 4,849,262.33 | 4,543,051.96 |
| 其他应付款合计 | 24,969,243.5 | 6,082,576.86 | 5,812,044.92 | 5,375,993.92 |
| 一年内到期的非流动负债 | 20,292,441.38 | 18,341,866.76 | 11,694,004.5 | 11,969,981.64 |
| 其他流动负债 | 1,461,318.17 | 2,146,478.81 | 1,610,690.02 | 1,271,717.9 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 326,155,400.73 | 314,170,964.15 | 261,426,763.42 | 134,659,958.78 |
| 非流动负债: | | | | |
| 长期借款 | 142,988,500 | 144,222,000 | 151,705,500 | 152,939,000 |
| 租赁负债 | 26,790,878.21 | 28,565,868.04 | 30,334,127.06 | 32,425,946.63 |
| 预计负债 | 2,977,761.45 | 2,670,391.45 | - | - |
| 递延收益 | 48,705,245.74 | 50,451,947.61 | 52,382,206.69 | 53,935,321.33 |
| 递延所得税负债 | 4,775,121.84 | 5,042,993.73 | 5,320,015.6 | 5,597,579.93 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 226,237,507.24 | 230,953,200.83 | 239,741,849.35 | 244,897,847.89 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 552,392,907.97 | 545,124,164.98 | 501,168,612.77 | 379,557,806.67 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 647,433,100 | 647,433,100 | 647,433,100 | 641,145,700 |
| 资本公积 | 1,446,277,690.32 | 1,445,337,486.87 | 1,450,269,707.4 | 1,440,912,916.66 |
| 其他综合收益 | -65,287.65 | 372,924.09 | 591,369.26 | 648,924.42 |
| 盈余公积 | 9,313,913.89 | 9,313,913.89 | 9,313,913.89 | 9,313,913.89 |
| 未分配利润 | -86,384,292.08 | -44,213,999.76 | 12,624,759.55 | 38,926,438.32 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,016,575,124.48 | 2,058,243,425.09 | 2,120,232,850.1 | 2,130,947,893.29 |
| 少数股东权益 | -3,842.53 | 124,635.43 | 95,131.33 | 116,710.9 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,016,571,281.95 | 2,058,368,060.52 | 2,120,327,981.43 | 2,131,064,604.19 |
| 负债和股东权益合计 | 2,568,964,189.92 | 2,603,492,225.5 | 2,621,496,594.2 | 2,510,622,410.86 |
| 公告日期 | 2024-04-29 | 2024-04-25 | 2023-10-26 | 2023-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |